Home » Topics » Analysis and data insight

Analysis and data insight
RSS

Biggest gainers and losers for May 1-5, 2023

May 8, 2023

The top 10 biopharma stock gainers and losers for the week.

BioWorld and Nasdaq stock indices

May 5, 2023

These graphs compare the performance of the biotech stocks for all of 2023 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Biopharma money raised: Jan. 1-May 4, 2023

May 5, 2023

Year-to-date money raised in public, private and other financings of biopharma companies.

Biopharma money raised by month in 2023 (US$M)

May 5, 2023

Biopharma money raised to-date and by month in 2023, including public, private and other financings.

Money raised by biopharma

May 5, 2023

Total raised in public, private and other financings of biopharma companies, comparing 2023 vs. 2022 vs. 2021 vs. 2020 vs. 2019.

Med-tech gainers and losers for April 24-28, 2023

May 1, 2023

The top 10 med-tech stock gainers and losers for the week.

Biggest gainers and losers for April 24-28, 2023

May 1, 2023

The top 10 biopharma stock gainers and losers for the week.

Biopharma money raised: Jan. 1-April 27, 2023

April 28, 2023

Year-to-date money raised in public, private and other financings of biopharma companies.

Money raised by biopharma

April 28, 2023

Total raised in public, private and other financings of biopharma companies, comparing 2023 vs. 2022 vs. 2021 vs. 2020 vs. 2019.

Women handshake with virology graphics

Med-tech deals and M&As sink in Q1; digital health dips

April 27, 2023

Despite a strong 2022 for both med-tech deals and M&As, the industry lost ground with both types of transactions in the first quarter of 2023, with deal values falling 32% and M&A values dropping 83%, in comparison with the first quarter of last year.